Acute Porphyria Drug Database

Monograph

D07AC03 - Desoximetasone
Not porphyrinogenic
NP

Rationale
Several references stating non-porphyrinogenicity of glucocorticoids.
Chemical description
Strong glucocorticoid, creme 0.25% used in dermatology. Risk for systemic exposure in application on large areas of the skin. Glucocorticoid: South African list: use. Kalman, Bonkovsky: believed to be safe. The Merck Manual: use. Moore MR, Hift RJ: Drugs in acute porphyria. Cell Mol Biol 43:89, 1997: safe. Tschudy DP, Lamon JM: Porphyrin metabolism and the Porphyrias in Bondy BK, Rosenberg LE (eds): Duncan’s Diseases of Metabolism, Philadelphia, WB Saunders 1980, p 939: safe.

Similar drugs
Explore alternative drugs in similar therapeutic classes D07A / D07AC or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Desoximetason · Desoximetason Bipharma 2,5 mg/g, hydrofobe crème · Topicorte · Topicorte, emulsie voor cutaan gebruik 2,5 mg/g
United Kingdom
Stiedex LP · Stiedex LP 0.05% oily cream
Norway
Desoximetason bipharma · Desoximetasone padagis
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙